Quantcast

Latest Prostate Stories

2014-02-23 23:02:43

The use of a new technology called High Intensity Focused Ultrasound (HIFU) waves to treat prostate cancer without surgery on an out-patient basis moves closer to U.S. approval thanks to Dr. Michael J. Lazar, Jr. and other urologists utilizing this next-generation technology with patients in other nations. SANTA ROSA, California (PRWEB) February 23, 2014 HIFU technology achieves pinpoint accuracy using an “acoustic scalpel” that destroys prostate cancer, while sparing healthy tissue...

2014-02-20 23:32:07

Profound Medical announces initiation of U.S. clinical trial for its novel, minimally invasive technology for the treatment of localized prostate cancer. Toronto, Ontario (PRWEB) February 20, 2014 Today, Profound Medical Inc. announced the initiation of the TULSA (Trans Urethral Ultrasound Ablation) clinical trial in the United States. The first US patient was treated on January 25, 2014 and the procedure was performed at Beaumont Hospital, Royal Oak by urologist, James Relle, M.D. “We...

2014-02-19 23:00:12

Research Study Testing Effectiveness of New Outpatient Treatment for Localized Prostate Cancer Royal Oak, MI (PRWEB) February 20, 2014 Urologists at Beaumont Hospital, Royal Oak are first in the U.S. to treat localized prostate cancer with a transurethral ultrasound therapy guided by magnetic resonance imaging. The experimental treatment is designed to potentially reduce the long-term complications of traditional prostate cancer treatments. The first treatment on Jan. 25 marked the launch...

2014-02-14 16:25:05

DALLAS, Feb. 14, 2014 /PRNewswire/ -- In his February 3, 2014 Op-Ed piece in The New York Times, Dr. John La Pluma says "men feel the loss" if their testosterone is lower than 220 to 350 ng/dl. La Pluma's misstatement of laboratory values is consistent with his glaring lack of knowledge relative to testosterone deficiency. (Photo: http://photos.prnewswire.com/prnh/20140214/DA65642) As the Medical Director for the largest hormone replacement company in the country with more...

2014-02-12 23:26:02

Prostate problems need not affect a man’s quality of life. Avail of Prosvent under the special 30-day trial period to get rid of prostate issues and enjoy better health. Los Angeles, Ca (PRWEB) February 12, 2014 With over 2 million bottles sold, Dr. Larry May’s Prosvent formula is indeed one of the most effective homeopathic treatment formulas for prostate-related problems. As men become older, prostate problems arise. Right now, almost 30 million males suffer from this condition. The...

2014-02-11 23:22:56

The marketing of therapy for low testosterone highlights the short-term benefits but serious concerns remain about possible long-term risks. Boston, MA (PRWEB) February 11, 2014 Millions of American men use a prescription testosterone gel, patch, or injection to boost levels of the manly hormone. The ongoing marketing blitz promises that treating "low T" this way can make men feel more alert, energetic, mentally sharp, and sexually functional. However, legitimate safety concerns...

2014-02-06 08:28:18

TORONTO, Feb. 6, 2014 /CNW/ - Men with metastatic castration-resistant prostate cancer (mCRPC) in Québec now have access to a therapy that can be used prior to chemotherapy. Effective February 3, 2014, the province has added ZYTIGA(®) (abiraterone acetate) to the public drug formulary for the treatment of mCRPC in men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy (ADT).(1) "ZYTIGA(® )provides men and health care professionals with a...

2014-02-03 23:20:56

Nomedexamlifeinsurance.com (http://nomedexamlifeinsurance.com) announces a new blog, “No Medical Exam Life Insurance For Prostate Cancer Patients.” (PRWEB) February 03, 2014 Nomedexamlifeinsurance.com has released a blog explaining the importance of having life insurance for prostate cancer patients! Prostate cancer patients will have difficulties finding an affordable life insurance plan. They will need to survey many policies and to compare numerous quotes before they can find...

2014-02-03 08:27:25

SAN DIEGO, Feb. 3, 2014 /PRNewswire/ -- GenomeDx Biosciences today announced that it has entered into a contractual agreement to provide its Decipher(®) prostate cancer test to FEDMED Payors. FEDMED is a national provider network that covers over 40 million lives. The Decipher( )prostate cancer classifier directly measures a patient's biological risk of developing metastatic prostate cancer. GenomeDx, which discovered and developed the Decipher test, will provide laboratory services...

2014-01-30 23:02:32

Mount Sinai experts share tips for prostate cancer prevention and new advancements in treatment and detection. New York, NY (PRWEB) January 30, 2014 Prostate cancer is the second leading cause of cancer death in American men. One in six men will be diagnosed with prostate cancer and 230,000 new cases are diagnosed annually. Overall, the five-year survival rate is 100 percent for men with the disease confined to the prostate or nearby tissue. Expert Available for Interview: Ash Tewari,...


Latest Prostate Reference Libraries

Prostate
2013-03-04 15:21:55

The male prostate gland acts as an exocrine gland in the male reproductive system. It is a firm, partly muscular, chestnut sized gland near the neck of the urethra in males. Formation and Orientation The prostate is usually formed within the ninth week of the embryonic stage in reproductive development. The prostate can be separated into either “lobes” or “zones”. When looking at a prostate divided into zones, there are four distinct regions. The first zone is the Peripheral...

More Articles (1 articles) »
Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.